1-2 of 2
Shanti Natarajan-Amé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena, Lionel Adès, Agnès Guerci, Odile Beyne-Rauzy, Marie-Pierre Gourin, Stephane Cheze, Aspasia Stamatoullas, Alessandro Sanna, Daniela Gioia, Gianni Cametti, Dario Ferrero, Emmanuel Raffoux, Christian Rose, Antonella Poloni, Thomas Prebet, Laurence Legros, Shanti Natarajan-Amé, Pierre Fenaux, Ulrich Germing, François Dreyfus, Sophie Park
Journal: Blood
Blood (2013) 122 (13): 2286–2288.
https://doi.org/10.1182/blood-2013-07-512442
Published: 2013
Journal Articles

Treatment of MDS with Excess Blasts by Bevacizumab Is Well Tolerated and Is Associated with a Decrease of VEGF Plasma Level.

Laurence Legros, Boranne Slama, Jean-Michel Karsenti, Norbert Vey, Shanti Natarajan-Ame, Eric Watel, Bruno Richard, Krimo Bouabdallah, Lionnel Mannone, Irit Touitou, Sebastien Huault, Jerome Durivault, Anne-Odile Hueber, Jean-Francois Michiels, Pierre Fenaux, Francois Dreyfus
Journal: Blood
Blood (2009) 114 (22): 2770.
https://doi.org/10.1182/blood.V114.22.2770.2770
Published: 2009